The Thin Line cover art

The Thin Line

Hope vs. Reality in the Era of Weight-Loss Drugs

Preview
Subscribe now Free with 30-day trial
Offer ends on 14 April, 2026 at 23:59.
Prime logo
Pay ₹5/month for 2 months and ₹199/month after 2 months, Cancel anytime. Offer ends on 14 April 2026 at 23:59. Take this offer!
1 credit a month to use on any title to download and keep.
Listen to anything from the Plus Catalogue—thousands of Audible Originals, podcasts and audiobooks.
Download titles to your library and listen offline.
1 credit a month to use on any title to download and keep
Listen to anything from the Plus Catalogue—thousands of Audible Originals, podcasts and audiobooks
Download titles to your library and listen offline
₹199 per month after 30-day trial. Cancel anytime.

The Thin Line

Written by: Scaachi Koul
Narrated by: Scaachi Koul
Subscribe now Free with 30-day trial

Pay ₹5/month for 2 months and ₹199/month after 2 months, Cancel anytime. Offer ends on 14 April 2026 at 23:59.

₹199 per month after trial ends. Cancel anytime.

Buy Now for ₹836.00

Buy Now for ₹836.00

LIMITED TIME OFFER | Get 2 Months for ₹5/month

About this listen

Over the next five years, millions of more Americans are expected to take Ozempic and other GLP-1 weight-loss drugs, which are rapidly being recognized as the miracle drugs of this century. If you’re not on them, you’ll probably know someone who is. What are the implications of the widespread use of these drugs, both on our bodies and our society? In this show, you’ll meet people across America who are either taking the jab or thinking about it, and the shocking intentional and unintentional results they are seeing. The Thin Line looks at the promise and the peril of GLP-1s today, and explores what will happen in the near future with the democratization of these breakthrough drugs.

©2025 Audible Originals LLC (P)2025 Audible Originals LLC
Diets, Nutrition & Healthy Eating Fitness, Diet & Nutrition Medicine & Health Care Industry Popular Culture Social Sciences Weight Loss & Weight Control
No reviews yet